Home > Journals > Otorinolaringologia > Past Issues > Otorinolaringologia 2010 March;60(1) > Otorinolaringologia 2010 March;60(1):11-3

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

OTORINOLARINGOLOGIA

A Journal on Otorhinolaryngology, Head and Neck Surgery,
Plastic Reconstructive Surgery, Otoneurosurgery


Indexed/Abstracted in: EMBASE, Scopus


eTOC

 

ORIGINAL ARTICLES  


Otorinolaringologia 2010 March;60(1):11-3

Copyright © 2010 EDIZIONI MINERVA MEDICA

language: Italian

Use of a compound containing N-acetyl-cysteine, echinacea, uncaria and propoles in antibiotic therapy for upper respiratory infections

Beatrice F., Bucolo S.

Struttura Complessa di Otorinolaringoiatria, Ospedale San Giovanni Bosco, ASL TO2, Torino, Italia


PDF  


The study compares two treatment approaches to upper respiratory infections as measured by patient self-report of changes in symptoms. The study population was divided into two homogeneous groups (age range, 18-25 years) and administered amoxicillin clavulanate, a commonly used antibiotic for such infections. One group received adjuvant antibiotic therapy with Prodefens, a compound containing N-acetyl-cysteine, echinacea, propolis and uncaria. The patients self-evaluated changes in 7 characteristic symptoms of upper respiratory infections on a 5-point Likert scale. As compared with the group given amoxicillin clavulanate alone, a significant reduction in symptom severity and duration was observed in the group that had received adjuvant antibiotic therapy with Prodefens. These preliminary results need to be substantiated with further studies on the therapeutic efficacy of combination therapy with Prodefens in the treatment of upper respiratory infections, given the increasing risk of bacterial resistance to widely used antibiotics.

top of page

Publication History

Cite this article as

Corresponding author e-mail